Summerville, SOUTH%20CAROLINA1 Active Studies

Ankylosing Spondylitis Clinical Trials in Summerville, SOUTH%20CAROLINA

Find 1 actively recruiting ankylosing spondylitis clinical trials in Summerville, SOUTH%20CAROLINA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
210
Enrolling

Recruiting Ankylosing Spondylitis Studies in Summerville

About Ankylosing Spondylitis Clinical Trials in Summerville

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Summerville, SOUTH%20CAROLINA. These studies are seeking a combined 210 participants. Research is being sponsored by Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company). Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Summerville — FAQ

Are there ankylosing spondylitis clinical trials in Summerville?

Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Summerville, SOUTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Summerville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Summerville research site will contact you about next steps.

Are clinical trials in Summerville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Summerville studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 1 active trials in Summerville are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov